South Africa’s cosmetic surgery and procedures industry is projected to generate $285 million in revenue by 2033, reflecting growing demand for aesthetic treatments and increasing investment in personal care.

The market generated an estimated $136.2 million in revenue in 2025, with projections indicating an increase to $152.2 million in 2026, according to industry market research.

The sector is expected to expand at a compound annual growth rate of 9.4 per cent between 2026 and 2033, as changing consumer preferences and rising disposable incomes continue to support demand.

Women accounted for the largest share of market revenue in 2025 and are also projected to remain the fastest-growing consumer segment throughout the forecast period.

Industry analysts attributed the market’s expansion partly to the increasing participation of women in the workforce, rising disposable incomes and rapid urbanisation, which have strengthened spending on beauty and personal care services.

South Africa’s cultural diversity and growing awareness of personal appearance are also contributing to demand for cosmetic treatments.

The market has equally recorded increased interest in skin-lightening and whitening procedures among different ethnic communities, while consumers are showing a preference for products and treatments featuring natural-based ingredients.

The industry covers both invasive and non-invasive cosmetic procedures, with market analysis also examining demand across three age categories: 13–29, 30–54 and 55 years and above.

Despite its projected growth, South Africa accounted for approximately 0.2 per cent of global cosmetic surgery and procedures market revenue in 2025.

Within the Middle East and Africa region, the United Arab Emirates is projected to lead the market by revenue in 2033, reaching an estimated $1.86 billion. The UAE is also identified as the region’s fastest-growing market.

Globally, Germany is projected to record the highest national market revenue by 2033.

Major international companies participating in the cosmetic surgery and procedures industry include AbbVie Inc., Cynosure, Evolus Inc., Revance Therapeutics Inc., Lumenis, Bausch Health Companies Inc., Candela Medical, Alma Lasers Ltd. and AirSculpt Technologies Inc.

The projections cover the period from 2026 to 2033, with 2025 serving as the market’s base year.